The worldwide prevalence of ADHD: is it an American condition?
- PMID: 16946911
- PMCID: PMC1525089
The worldwide prevalence of ADHD: is it an American condition?
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a behavioral disorder that affects up to 1 in 20 children in the USA. The predominance of American research into this disorder over the past 40 years has led to the impression that ADHD is largely an American disorder and is much less prevalent elsewhere. This impression was reinforced by the perception that ADHD may stem from social and cultural factors that are most common in American society. However, another school of thought suggested that ADHD is a behavioral disorder common to children of many different races and societies worldwide, but that is not recognized by the medical community, perhaps due to confusion regarding its diagnosis and/or misconceptions regarding its adverse impact on children, their families, and society as a whole. In this article we present the available data, with a view to determining the worldwide prevalence of ADHD. A total of 50 studies were identified from a MEDLINE search for the terms ADHD, ADD, HKD, or attention-deficit/hyperactivity disorder and prevalence combined, for the years 1982 to 2001. 20 were studies in US populations and 30 were in non-US populations. Analysis of these studies suggests that the prevalence of ADHD is at least as high in many non-US children as in US children, with the highest prevalence rates being seen when using DSM-IV diagnoses. Recognition that ADHD is not purely an American disorder and that the prevalence of this behavioral disorder in many countries is in the same range as that in the USA will have important implications for the psychiatric care of children.
Similar articles
-
Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.J Child Psychol Psychiatry. 2006 May;47(5):472-9. doi: 10.1111/j.1469-7610.2005.01590.x. J Child Psychol Psychiatry. 2006. PMID: 16671930
-
Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.JAMA Netw Open. 2019 Nov 1;2(11):e1914344. doi: 10.1001/jamanetworkopen.2019.14344. JAMA Netw Open. 2019. PMID: 31675080 Free PMC article.
-
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972
-
Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals: A Systematic Review and Meta-analysis.JAMA Psychiatry. 2021 Jan 1;78(1):21-28. doi: 10.1001/jamapsychiatry.2020.2788. JAMA Psychiatry. 2021. PMID: 32902608 Free PMC article.
-
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.JAMA. 1998 Apr 8;279(14):1100-7. doi: 10.1001/jama.279.14.1100. JAMA. 1998. PMID: 9546570 Review.
Cited by
-
Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later.Arch Gen Psychiatry. 2012 Dec;69(12):1295-303. doi: 10.1001/archgenpsychiatry.2012.271. Arch Gen Psychiatry. 2012. PMID: 23070149 Free PMC article.
-
Agreement Among Categorical, Dimensional, and Impairment Criteria for ADHD and Common Comorbidities.J Atten Disord. 2016 Aug;20(8):665-73. doi: 10.1177/1087054712475083. Epub 2013 Feb 11. J Atten Disord. 2016. PMID: 23400215 Free PMC article.
-
Cognitive stimulation in socioeconomically disadvantaged children with neurodevelopmental disorders: a case series.Front Psychol. 2024 Jul 9;15:1365697. doi: 10.3389/fpsyg.2024.1365697. eCollection 2024. Front Psychol. 2024. PMID: 39045438 Free PMC article.
-
Validity of Diagnostic Support Model for Attention Deficit Hyperactivity Disorder: A Machine Learning Approach.J Pers Med. 2023 Oct 24;13(11):1525. doi: 10.3390/jpm13111525. J Pers Med. 2023. PMID: 38003840 Free PMC article.
-
Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine.Child Adolesc Psychiatry Ment Health. 2013 May 6;7(1):14. doi: 10.1186/1753-2000-7-14. Child Adolesc Psychiatry Ment Health. 2013. PMID: 23648011 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.
-
- Biederman J. Wilens T. Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study . J Am Acad Child Adolesc Psychiatry. 1997;36:21–29. - PubMed
-
- Mash EJ. Johnston C. Parental perceptions of child behavior problems, parenting self-esteem, and mothers' reported stress in younger and older hyperactive and normal children. J Consult Clin Psychol. 1983;51:86–99. - PubMed
-
- Murphy KR. Barkley RA. Parents of children with attentiondeficit/ hyperactivity disorder: psychological and attentional impairment. Am J Orthopsychiatry. 1996;66:93–102. - PubMed
-
- Taylor E. Sandberg S. Hyperactive behavior in English schoolchildren: a questionnaire survey. J Abnorm Child Psychol. 1984;12:143–155. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous